Glasswatch
A creator-facing observability workspace that connects approved runtime, deployment, payment, and agent signals, translates bounded symptoms into plain language, opens prioritized cases, and preserves source links, uncertainty, owner actions, recovery, readback, and correction.
The source record contains only a product hypothesis and explicitly says competitive and technical research is pending. No provider, interface, pricing, market gap, or structural moat is verified. Glasswatch can be authored as a direction to investigate, but it must not claim that the category is empty, that any named no-code deployment surface exposes sufficient telemetry, or that revenue and agent failures can be diagnosed from one integration.
The product should separate observation, symptom, correlation, hypothesis, owner, action, provider state, and recovery. A payment-volume drop does not prove the app is broken; a health check does not prove customers can complete a transaction; a model error does not identify root cause; and a daily digest cannot infer revenue impact without approved finance evidence.
Glasswatch should begin read-only with a small, verified connector set and let creators define critical journeys, expected states, notification channels, quiet hours, data boundaries, and escalation contacts. Plain language must include source and uncertainty. The tool never restarts production, changes configuration, touches funds, contacts customers, or claims root cause autonomously.
Nontechnical creators and small teams operating revenue-generating apps or agents who need understandable incident signals and guided ownership without a full infrastructure team.
Creator-built apps and agents create a current operational need if validated.
Creators operating apps or agents are specific.
The source reports a trend signal but no verified research.
The creator buyer, plain-language incident artifact, critical journeys, read-only evidence, and recovery workflow are concrete hypotheses.
All research is pending, interfaces and buyer willingness are unverified, no moat is stated, observability competition is likely, and diagnosis across opaque platforms can be unreliable.
Discussion
No comments yet — be the first to weigh in.
